Pulse Biosciences (PLSE) Beginning Cash Balance (2023)
Pulse Biosciences (PLSE) recorded quarterly Beginning Cash Balance of $828000.0 in Q2 2023, down 9.71% quarter-over-quarter from $917000.0 in Q1 2023.
Pulse Biosciences (PLSE) Beginning Cash Balance (2023) Analysis & Trends
Pulse Biosciences' Beginning Cash Balance history runs 1 years deep, the most recent figure standing at $828000.0 for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 828,000.00 |
| Jun 30, 2023 | 828,000.00 |
| Mar 31, 2023 | 917,000.00 |
| Mar 31, 2023 | 917,000.00 |